Top Premarket Decliners

MT Newswires Live

Sep 03

Ultragenyx Pharmaceutical (RARE) shares were down 50% in premarket activity Thursday after the company said overnight that its phase 3 Aspire study of apazunersen in Angelman syndrome - a rare neurogenetic disorder - failed to meet the primary endpoint and a key secondary endpoint.

Research Alliance (RACC) stock was 21% lower, extending the 3.7% fall in the previous session.

Victoria's Secret (VSXY) shares were down 16% following its fiscal Q2 results.

Methode Electronics (MEI) stock was 14% lower after the company posted a wider-than-expected fiscal Q1 adjusted loss late Wednesday.

Advasa (ADBT) shares were down 12% after a more than 53% fall at the previous close when the company said it added USDC (USDC-USD) payments to its Visa card.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/news/2664797048"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664797048\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664797048?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-03 19:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664797048","market":"hk","top_or_hot":-1,"title":"Top Premarket Decliners","media":"MT Newswires Live","content":"<html><body><p> Ultragenyx Pharmaceutical (RARE) shares were down 50% in premarket activity Thursday after the company said overnight that its phase 3 Aspire study of apazunersen in Angelman syndrome - a rare neurogenetic disorder - failed to meet the primary endpoint and a key secondary endpoint.</p><p>Research Alliance (RACC) stock was 21% lower, extending the 3.7% fall in the previous session.</p><p><a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>'s Secret (VSXY) shares were down 16% following its fiscal Q2 results.</p><p>Methode Electronics (MEI) stock was 14% lower after the company posted a wider-than-expected fiscal Q1 adjusted loss late Wednesday.</p><p>Advasa (ADBT) shares were down 12% after a more than 53% fall at the previous close when the company said it added USDC (USDC-USD) payments to its Visa card.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Premarket Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Premarket Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-09-03 19:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Ultragenyx Pharmaceutical (RARE) shares were down 50% in premarket activity Thursday after the company said overnight that its phase 3 Aspire study of apazunersen in Angelman syndrome - a rare neurogenetic disorder - failed to meet the primary endpoint and a key secondary endpoint.</p><p>Research Alliance (RACC) stock was 21% lower, extending the 3.7% fall in the previous session.</p><p><a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>'s Secret (VSXY) shares were down 16% following its fiscal Q2 results.</p><p>Methode Electronics (MEI) stock was 14% lower after the company posted a wider-than-expected fiscal Q1 adjusted loss late Wednesday.</p><p>Advasa (ADBT) shares were down 12% after a more than 53% fall at the previous close when the company said it added USDC (USDC-USD) payments to its Visa card.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4094","symbol_name":"服装零售","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2664797048","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664797048","pubTimestamp":1788435423,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Ultragenyx Pharmaceutical  shares were down 50% in premarket activity Thursday after the company said overnight that its phase 3 Aspire study of apazunersen in Angelman syndrome - a rare neurogenetic disorder - failed to meet the primary endpoint and a key secondary endpoint.Research Alliance  stock was 21% lower, extending the 3.7% fall in the previous session.Victoria's Secret  shares were down 16% following its fiscal Q2 results.Methode Electronics  stock was 14% lower after the company posted a wider-than-expected fiscal Q1 adjusted loss late Wednesday.Advasa  shares were down 12% after a more than 53% fall at the previous close when the company said it added USDC  payments to its Visa card.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4094":"服装零售","BK4145":"电子制造服务","MEI.AU":"METEORIC RESOURCES NL","ADBT":"Advasa Holdings (Direct Listing)","MEI":"Methode Electronics Inc","BK4023":"应用软件","RARE":"Ultragenyx Pharmaceutical Inc","BK4139":"生物科技","BK7095":"多种金属与采矿","VSXY":"维多利亚的秘密","RACC":"Research Alliance III (Stock-Only SPAC)"},"translate_title":"盘前跌幅最大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ADBT":1,"VSXY":1,"RACC":1,"MEI":1,"MEI.AU":1,"RARE":1},"content_text":"Ultragenyx Pharmaceutical (RARE) shares were down 50% in premarket activity Thursday after the company said overnight that its phase 3 Aspire study of apazunersen in Angelman syndrome - a rare neurogenetic disorder - failed to meet the primary endpoint and a key secondary endpoint.Research Alliance (RACC) stock was 21% lower, extending the 3.7% fall in the previous session.Victoria's Secret (VSXY) shares were down 16% following its fiscal Q2 results.Methode Electronics (MEI) stock was 14% lower after the company posted a wider-than-expected fiscal Q1 adjusted loss late Wednesday.Advasa (ADBT) shares were down 12% after a more than 53% fall at the previous close when the company said it added USDC (USDC-USD) payments to its Visa card.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}